Annual report
7716.TEDINET S100VFKM
Period2024-01-01 → 2024-12-31
Filed2025-03-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥77.0bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥59.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥48.7bn | 2022-01-01 → 2022-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥44.9bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥33.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥14.6bn | 2024-01-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥14.3bn | 2023-01-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥17.3bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.2bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥17.6bn | 2022-01-01 → 2022-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.0bn | 2021-01-01 → 2021-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.6bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥13.7bn | 2024-01-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥28.8bn | 2023-01-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥22.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.5bn | 2022-01-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.1bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.5bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥8.6bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥22.8bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥158.3bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥140.8bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥102.6bn | at 2022-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥94.5bn | at 2021-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥82.5bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.1bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥27.6bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥121.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥113.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥91.0bn | at 2022-12-31d | Cons. | Net assets |
| Net assets / equity | ¥82.9bn | at 2021-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥76.3bn | at 2020-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥46.1bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥31.7bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥35.2bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥26.0bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥31.6bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.9bn | at 2021-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥30.0bn | at 2020-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥15.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.8bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥9.2bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥19.1bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.3bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.1bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥599m | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.4bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥6.1bn | 2022-01-01 → 2022-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.7bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥101.37 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥267.62 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥145.48 | 2022-01-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.73 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.49 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥101.06 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥266.87 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥145.11 | 2022-01-01 → 2022-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.47 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥74.34 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,430.58 | at 2024-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,322.75 | at 2023-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,065.57 | at 2022-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥959.59 | at 2021-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥877.95 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 76.3% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.1% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.4% | at 2022-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.3% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.3% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.4% | 2023-01-01 → 2023-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.4% | 2022-01-01 → 2022-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,180 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 2,049 | at 2023-12-31 | Cons. | Number of employees |
| Employees | 1,478 | at 2022-12-31d | Cons. | Number of employees |
| Employees | 1,239 | at 2021-12-31d | Cons. | Number of employees |
| Employees | 1,184 | at 2020-12-31d | Cons. | Number of employees |
| Revenue | ¥34.3bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥36.7bn | 2023-01-01 → 2023-12-31 | Standalone | Net sales |
| Revenue | ¥34.4bn | 2022-01-01 → 2022-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥32.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥25.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥9.0bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Operating income | ¥10.1bn | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Ordinary income | ¥11.4bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥15.7bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥15.7bn | 2022-01-01 → 2022-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.8bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥8.6bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥15.6bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Net income | ¥6.2bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥12.1bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | ¥11.8bn | 2022-01-01 → 2022-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥102.1bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥95.1bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥77.1bn | at 2022-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥71.6bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥65.9bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥23.1bn | at 2024-12-31 | Standalone | Liabilities |
| Total liabilities | ¥16.3bn | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥79.0bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥78.8bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥69.9bn | at 2022-12-31d | Standalone | Net assets |
| Net assets / equity | ¥64.6bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥61.8bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥16.2bn | at 2024-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥10.7bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥73.79 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥141.8 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.22 | 2022-01-01 → 2022-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.97 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.48 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥73.57 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥141.41 | 2023-01-01 → 2023-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥136.88 | 2022-01-01 → 2022-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥82.79 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥54.37 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥52 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2023-01-01 → 2023-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥46 | 2022-01-01 → 2022-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥37 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥930.73 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥919.68 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥817.09 | at 2022-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥746.98 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥710.8 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 77.0% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.5% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.3% | at 2022-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.4% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.0% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.3% | 2023-01-01 → 2023-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2022-01-01 → 2022-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 93,418,200 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2022-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,100 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 1,060 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 1,004 | at 2022-12-31d | Standalone | Number of employees |
| Employees | 906 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 869 | at 2020-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 79
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥1.2bn |
| Reconciling Itemsreconciling | depreciation | 2024-01-01 → 2024-12-31 | ¥515m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥214m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-12-31 | −¥214m |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥66.4bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥5.7bn |
| DCI Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥80m |
| DCI Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥1.1bn |
| DCI Productsreportable segment | employees | at 2024-12-31 | 389 pure |
| DCI Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥19.5bn |
| DCI Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥19.5bn |
| DCI Productsreportable segment | segment assets | at 2024-12-31 | ¥46.8bn |
| DCI Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥90m |
| Dental Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥2.9bn |
| Dental Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥2.0bn |
| Dental Productsreportable segment | employees | at 2024-12-31 | 994 pure |
| Dental Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥46.7bn |
| Dental Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥46.5bn |
| Dental Productsreportable segment | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥214m |
| Dental Productsreportable segment | segment assets | at 2024-12-31 | ¥35.2bn |
| Dental Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥17.1bn |
| Industrial Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥610m |
| Industrial Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥446m |
| Industrial Productsreportable segment | employees | at 2024-12-31 | 240 pure |
| Industrial Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥6.7bn |
| Industrial Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥6.7bn |
| Industrial Productsreportable segment | segment assets | at 2024-12-31 | ¥8.2bn |
| Industrial Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥825m |
| Surgical Productsreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥506m |
| Surgical Productsreportable segment | depreciation | 2024-01-01 → 2024-12-31 | ¥129m |
| Surgical Productsreportable segment | employees | at 2024-12-31 | 147 pure |
| Surgical Productsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥4.3bn |
| Surgical Productsreportable segment | revenue external | 2024-01-01 → 2024-12-31 | ¥4.3bn |
| Surgical Productsreportable segment | segment assets | at 2024-12-31 | ¥1.7bn |
| Surgical Productsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥2.3bn |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥4.1bn |
| —segment total | depreciation | 2024-01-01 → 2024-12-31 | ¥3.7bn |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥77.3bn |
| —segment total | revenue external | 2024-01-01 → 2024-12-31 | ¥77.0bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-12-31 | ¥214m |
| —segment total | segment assets | at 2024-12-31 | ¥91.9bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥20.2bn |
| Reconciling Itemsreconciling | capex | 2023-01-01 → 2023-12-31 | ¥1.3bn |
| Reconciling Itemsreconciling | depreciation | 2023-01-01 → 2023-12-31 | ¥559m |
| Reconciling Itemsreconciling | segment assets | at 2023-12-31 | ¥57.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-12-31 | −¥5.5bn |
| DCI Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥194m |
| DCI Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥224m |
| DCI Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥4.0bn |
| DCI Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥4.0bn |
| DCI Productsreportable segment | segment assets | at 2023-12-31 | ¥41.2bn |
| DCI Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | −¥534m |
| Dental Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥3.2bn |
| Dental Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥1.7bn |
| Dental Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥44.4bn |
| Dental Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥44.4bn |
| Dental Productsreportable segment | segment assets | at 2023-12-31 | ¥28.9bn |
| Dental Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥17.2bn |
| Industrial Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥641m |
| Industrial Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥400m |
| Industrial Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥7.6bn |
| Industrial Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥7.6bn |
| Industrial Productsreportable segment | segment assets | at 2023-12-31 | ¥9.9bn |
| Industrial Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.2bn |
| Surgical Productsreportable segment | capex | 2023-01-01 → 2023-12-31 | ¥616m |
| Surgical Productsreportable segment | depreciation | 2023-01-01 → 2023-12-31 | ¥96m |
| Surgical Productsreportable segment | revenue | 2023-01-01 → 2023-12-31 | ¥3.8bn |
| Surgical Productsreportable segment | revenue external | 2023-01-01 → 2023-12-31 | ¥3.8bn |
| Surgical Productsreportable segment | segment assets | at 2023-12-31 | ¥3.6bn |
| Surgical Productsreportable segment | segment profit | 2023-01-01 → 2023-12-31 | ¥1.9bn |
| —segment total | capex | 2023-01-01 → 2023-12-31 | ¥4.7bn |
| —segment total | depreciation | 2023-01-01 → 2023-12-31 | ¥2.4bn |
| —segment total | revenue | 2023-01-01 → 2023-12-31 | ¥59.7bn |
| —segment total | revenue external | 2023-01-01 → 2023-12-31 | ¥59.7bn |
| —segment total | segment assets | at 2023-12-31 | ¥83.7bn |
| —segment total | segment profit | 2023-01-01 → 2023-12-31 | ¥19.7bn |
| Dental Productsreportable segment | employees | at 2024-12-31 | 539 pure |
| Industrial Productsreportable segment | employees | at 2024-12-31 | 108 pure |
| Surgical Productsreportable segment | employees | at 2024-12-31 | 134 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,700
| Item | Context | Value | Unit |
|---|---|---|---|
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.2814 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 5066000 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.0599 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 4983000 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0590 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 4530000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0536 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 4362000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0516 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 3721000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0440 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 3369000 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0399 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 3120000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0369 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 2802000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0331 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 2798000 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0331 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 2265000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0268 | |
| Number of shares held | CurrentYearInstant_No11MajorShareholdersMember | 2265000 | |
| Shareholding ratio | CurrentYearInstant_No11MajorShareholdersMember | 0.0268 | |
| Number of shares held | CurrentYearInstant | 39283000 | |
| Shareholding ratio | CurrentYearInstant | 0.4651 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 8961100 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 84426200 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 844262 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 30900 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 93418200 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 844262 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 8961118 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 8961118 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0959 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 8961118 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 8961118 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0959 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 2195885000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 26 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 2195884000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 26 | |
| Number of male directors and other officers | FilingDateInstant | 7 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.222 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |